TABLE 1

Baseline parameters of the participants

Control groupTreatment groupP
n1214
BMI (kg/m2)32.8 ± 0.933.7 ± 0.90.467
Age (years)35.0 ± 2.032.5 ± 1.80.3573
Height (m)1.64 ± 0.031.67 ± 0.020.3453
Weight (kg)89.0 ± 4.794.6 ± 3.40.3300
Female/male11/111/3
Leptin (ng/ml)283 ± 24325 ± 500.4561
Adiponectin (μg/ml)111.4 ± 11.383.6 ± 9.50.0707
Insulin (pmol/l)26.7 ± 8.534.5 ± 4.70.4151
Glucose (mmol/l)4.61 ± 0.094.76 ± 0.110.3430
Cholesterol (mmol/l)4.71 ± 0.264.66 ± 0.190.8820
HDL (mmol/l)1.07 ± 0.061.12 ± 0.090.6747
Ghrelin (pmol/l)493 ± 87371 ± 650.2627
Peptide YY (pmol/l)11.8 ± 1.612.2 ± 2.10.8881
  • Data are means ± SE. An unpaired t test was used to compare values between the two groups.